{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:49:26Z","timestamp":1790790566589,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T00:00:00Z","timestamp":1688515200000},"content-version":"vor","delay-in-days":369,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.jacc.2022.04.039","type":"journal-article","created":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T16:13:09Z","timestamp":1656346389000},"page":"36-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Cardiovascular Risks of Hydroxychloroquine vs Methotrexate in Patients With Rheumatoid\u00a0Arthritis"],"prefix":"10.1016","volume":"80","author":[{"given":"Elvira","family":"D\u2019Andrea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi J.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengdong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Glynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Weinblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seoyoung C.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2022.04.039_bib1","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/art.41752","article-title":"2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis","volume":"73","author":"Fraenkel","year":"2021","journal-title":"Arthritis-Rheumatol"},{"key":"10.1016\/j.jacc.2022.04.039_bib3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13075-017-1366-1","article-title":"Factors associated with initial or subsequent choice of biologic disease-modifying antirheumatic drugs for treatment of rheumatoid arthritis","volume":"19","author":"Jin","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jacc.2022.04.039_bib4","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s40264-018-0689-4","article-title":"Cardiac complications attributed to chloroquine and hydroxychloroquine: a systematic review of the literature","volume":"41","author":"Chatre","year":"2018","journal-title":"Drug Saf"},{"key":"10.1016\/j.jacc.2022.04.039_bib5","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1136\/annrheumdis-2019-216653","article-title":"Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update-of the EULAR-recommendations-for the-management of rheumatoid arthritis","volume":"79","author":"Sepriano","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jacc.2022.04.039_bib6","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/RHU.0000000000000502","article-title":"Use of hydroxychloroquine is associated with improved lipid profile in rheumatoid arthritis patients","volume":"23","author":"Restrepo","year":"2017","journal-title":"J\u00a0Clin Rheumatol"},{"key":"10.1016\/j.jacc.2022.04.039_bib7","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1001\/jama.2011.878","article-title":"Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis","volume":"305","author":"Solomon","year":"2011","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.jacc.2022.04.039_bib8","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.semarthrit.2021.10.001","article-title":"Risk of venous thromboembolism associated with methotrexate versus hydroxychloroquine for rheumatoid arthritis: a cohort study","volume":"51","author":"He","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jacc.2022.04.039_bib9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41584-020-0372-x","article-title":"Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology","volume":"16","author":"Schrezenmeier","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jacc.2022.04.039_bib10","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12916-018-1188-2","article-title":"The arrhythmogenic cardiotoxicity of the quinoline and structurally related antimalarial drugs: a systematic review","volume":"16","author":"Haeusler","year":"2018","journal-title":"BMC Med"},{"key":"10.1016\/j.jacc.2022.04.039_bib11","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/rheumatology\/kel402","article-title":"Heart conduction disorders related to antimalarials toxicity: an analysis of electrocardiograms in 85 patients treated with hydroxychloroquine for connective tissue diseases","volume":"46","author":"Costedoat-Chalumeau","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.jacc.2022.04.039_bib12","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4269\/ajtmh.2002.67.54","article-title":"The effects of antimalarial drugs on ventricular repolarization","volume":"67","author":"Touze","year":"2002","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.jacc.2022.04.039_bib13","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1517\/14740338.4.3.421","article-title":"Antimalarial drugs: QT prolongation and cardiac arrhythmias","volume":"4","author":"Traebert","year":"2005","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jacc.2022.04.039_bib14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1136\/hrt.81.2.221","article-title":"Chloroquine cardiomyopathy with conduction disorders","volume":"81","author":"Baguet","year":"1999","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2022.04.039_bib15","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3109\/08923973.2013.780078","article-title":"Chloroquine cardiomyopathy - a review of the literature","volume":"35","author":"T\u00f6nnesmann","year":"2013","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1016\/j.jacc.2022.04.039_bib16","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1161\/CIR.0000000000000426","article-title":"Drugs that may cause or exacerbate heart failure: a scientific statement from the American Heart Association","volume":"134","author":"Page","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2022.04.039_bib17","doi-asserted-by":"crossref","first-page":"R32","DOI":"10.1186\/ar3260","article-title":"Validation of rheumatoid arthritis diagnoses in health care utilization data","volume":"13","author":"Kim","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jacc.2022.04.039_bib18","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/pds.1869","article-title":"Validation of diagnostic codes for outpatient originating sudden cardiac death and ventricular arrhythmia in Medicaid and Medicare claims data","volume":"19","author":"Hennessy","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jacc.2022.04.039_bib19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ahj.2004.02.013","article-title":"Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value based on review of hospital records","volume":"148","author":"Kiyota","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2022.04.039_bib20","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/pds.1924","article-title":"Validation of claims-based diagnostic and procedure codes for cardiovascular and gastrointestinal serious adverse events in a commercially insured population","volume":"19","author":"Wahl","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jacc.2022.04.039_bib21","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1161\/01.STR.0000032240.28636.BD","article-title":"Validating administrative data in stroke research","volume":"33","author":"Tirschwell","year":"2002","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.jacc.2022.04.039_bib22","article-title":"Comparison of expert adjudicated coronary heart disease and cardiovascular disease mortality with the National Death Index: results from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study","volume":"6","author":"Olubowale","year":"2017","journal-title":"J\u00a0Am-Heart Assoc"},{"issue":"Suppl 1","key":"10.1016\/j.jacc.2022.04.039_bib23","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/pds.2313","article-title":"A\u00a0systematic review of validated methods for identifying heart failure using administrative data","volume":"21","author":"Saczynski","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jacc.2022.04.039_bib24","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jclinepi.2010.10.004","article-title":"A\u00a0combined comorbidity score predicted mortality in elderly patients better than existing scores","volume":"64","author":"Gagne","year":"2011","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jacc.2022.04.039_bib25","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/gerona\/glx229","article-title":"Measuring frailty in Medicare data: development and validation of a claims-based frailty index","volume":"73","author":"Kim","year":"2018","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jacc.2022.04.039_bib26","first-page":"3083","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat\u2217Med."},{"issue":"6","key":"10.1016\/j.jacc.2022.04.039_bib27","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/CIRCULATIONAHA.115.017719","article-title":"Introduction to the analysis of survival data in the presence of competing risks","volume":"133","author":"Austin","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2022.04.039_bib28","doi-asserted-by":"crossref","first-page":"106057","DOI":"10.1016\/j.ijantimicag.2020.106057","article-title":"Cardiac effects and toxicity of chloroquine: a short update","volume":"56","author":"Mubagwa","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jacc.2022.04.039_bib29","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1002\/art.41934","article-title":"American College of Rheumatology white paper on antimalarial cardiac toxicity","volume":"73","author":"Desmarais","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"10.1016\/j.jacc.2022.04.039_bib30","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1002\/art.41803","article-title":"Cardiovascular safety of hydroxychloroquine in US veterans with rheumatoid arthritis","volume":"73","author":"Faselis","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jacc.2022.04.039_bib31","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.sapharm.2020.04.016","article-title":"Safety signals for QT prolongation or Torsades-de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine","volume":"17","author":"Sarayani","year":"2021","journal-title":"Res-Social Adm Pharm"},{"key":"10.1016\/j.jacc.2022.04.039_bib32","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/bcp.14546","article-title":"Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: a comprehensive pharmacovigilance analysis of pre-COVID-19 reports","volume":"87","author":"Goldman","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jacc.2022.04.039_bib33","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1161\/CIRCULATIONAHA.120.048238","article-title":"Cardiovascular toxicities associated with hydroxychloroquine and azithromycin: an analysis of the World Health Organization Pharmacovigilance Database","volume":"142","author":"Nguyen","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2022.04.039_bib34","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1136\/hrt.80.5.432","article-title":"Prevention of relapse in patients with congestive heart failure: the role of precipitating factors","volume":"80","author":"Feenstra","year":"1998","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2022.04.039_bib35","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.amjcard.2011.06.054","article-title":"Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease","volume":"108","author":"Micha","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2022.04.039_bib36","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJMoa1809798","article-title":"CIRT Investigators. Low-dose methotrexate for the prevention of atherosclerotic events","volume":"380","author":"Ridker","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.jacc.2022.04.039_bib37","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-043961","article-title":"How well can we assess the validity of non-randomised studies of medications? A systematic review of assessment tools","volume":"11","author":"D'Andrea","year":"2021","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.jacc.2022.04.039_bib38","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s40471-015-0053-5","article-title":"The active comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary application","volume":"2","author":"Lund","year":"2015","journal-title":"Curr Epidemiol Rep"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073510972204935X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073510972204935X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:49:26Z","timestamp":1760017766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073510972204935X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S073510972204935X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2022.04.039","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742220888.793595100","asserted-by":"object"}]},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular Risks of Hydroxychloroquine vs Methotrexate in Patients With Rheumatoid\u00a0Arthritis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2022.04.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}